Magnitude Biosciences Celebrates Seven Years at the Heart of NETPark
- Sep 26, 2025
- 1 min read
From an academic idea to a thriving high-growth biotech company, NETPark-based Magnitude Biosciences Ltd is celebrating seven years of scientific innovation and commercial success.
A spin-out from Durham University, Magnitude was founded in 2018 with a clear mission: to revolutionise how researchers study ageing, toxicity, and drug efficacy using C. elegans, a tiny but powerful model organism. Since then, the company has grown into a leading contract research organisation (CRO), employing over 20 team members and supporting partners across the biotech, pharmaceutical, nutraceutical and cosmeceutical sectors.
.png)
